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Effectiveness of an Information-Motivation-Behavioral Skills – based Educational Intervention 
to Promote Gardasil Use Among Female Undergraduate Students
Giselle Katiria Perez, Ph.D.
University of Connecticut, 2013
Cervical cancer is a virally mediated disease with the majority of cases due to the human 
papillomavirus (HPV).  HPV infections are the most prominent sexually transmitted diseases 
among college women.  Although vaccines such as Gardasil afford women with a valuable 
method of cancer prevention, vaccination rates are often incomplete or inadequate. This study 
evaluated the effectiveness of an interactive, information-motivation-behavioral skills (IMB) 
based, multimodal program to promote Gardasil use among 62 undergraduate women enrolled at 
the University of Connecticut.  Secondary aims targeted additional health behaviors, including 
risky sexual practices and Pap Screen utilization.  Participants were randomly assigned to a 
single-session intervention group or an attention control group and were assessed pre- and post-
intervention and at a 1-month follow-up.  At baseline, a majority of women demonstrated high 
levels of vaccine knowledge, low mastery of HPV/cervical cancer information, and ambivalence 
about pursuing vaccination.  Following the intervention, the IMB group demonstrated increased 
levels of HPV/cervical cancer and Gardasil knowledge, higher levels of motivation and 
intentions to get vaccinated, and more positive attitudes toward vaccination.  Women in the IMB 
group also demonstrated greater intentions to engage in regular screening.  These results provide 
support for an IMB program to impact women’s decision to get vaccinated and engage in cancer 
prevention.  Findings may help guide the development of a cost-effective, cancer preventive 
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program that can be easily disseminated and implemented in university clinics and health 
centers.  
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Cervical cancer is one of the most prevalent forms of cancer diagnosed in women 
globally (Collins, Einstein, Gostout, Herzog, Massad, Rader, et al, 2006).   The economical and 
societal burden of this disease is substantial, as it is estimated that approximately 12,000 new 
cases and about 4,000 deaths will occur each year in the United States (Center for Disease 
Control and Prevention (CDC), 2011a).  There are several risk factors that have been posited to 
increase women’s susceptibility to developing cervical carcinoma, including smoking, diet, 
immunosuppression, use of birth control pills, and giving birth to more than 3 children 
(American Cancer Society (ACS), 2010).  Of these multiple risk factors, infection with Human 
Papillomavirus (HPV) has been evidenced to be one of the primary causes of cervical cancer 
(Collins et al, 2006; Franco, Schlecht, & Saslow, 2003). 
 HPV are a family of over 150 small, double-stranded DNA viruses, of which 40 are 
characterized as sexually transmissible.  These genital subtypes are further categorized as high 
risk or low risk based on their oncogenic properties, with high risk strains implicated in cancers 
of the cervix, vulva, anus, and penis (Veldhuijzen, Snijders, Reiss, Meijer, & van de Wjgert, 
2010) and low risk HPV leading to genital warts (National Cancer Institute (NCI), 2011).  
Amongst the 15 high-risk, cancer-causing strains, subtypes 16 and 17 are the most common and 
have been linked to 70% of cervical cancers (NCI, 2011). 
The evidence depicting cervical cancer as a virally mediated disease is indisputable; 
studies have shown that 99.7% of all cases of cervical cancer have confirmed HPV DNA 
(Montalvo, Lobato, Villanueva, Borquez, Navarette, Abarca, et al, 2011).  Sexual contact with an 
infected person transmits the virus through micro-abrasions in the cervix, infecting the basal cells 
of the cervical epithelium.  Subsequent invasion of the host cell yields expression of several 
viral-specific oncogenic proteins, particularly E6 and E7, whose main function is to disable vital 
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tumor suppressing agents thereby enabling unrestrained aberrant cell replication (Jensen, 
Lehman, Antoni, & Pereira, 2007; Veldhuijzen et al, 2010).  These cellular changes in the cervix 
are often transient; in fact, a healthy immune system is capable of effectively eliminating the 
virus from the body within 2 years of infection (CDC, 2011a).  However, persistent infection 
with high-risk strains facilitates integration of viral DNA into the host genome leading to lasting 
cellular transformations (Jensen et al, 2007).  If left untreated, these cellular changes accelerate 
disease pathogenesis and ultimately become cervical cancer.     
 
Prevalence and Awareness of HPV 
HPV infection of the anogenital region is highly communicable.  Established as one of 
the most common sexually transmitted diseases (Garcia & Saslow, 2007), as many as 50% of 
sexually active individuals are likely to get HPV at some point in their lifetime (CDC, 2011a).  
Epidemiological studies have documented a parabolic relationship between age and risk of HPV 
infection; specifically, incidence rates have been shown to steadily rise with increasing age, 
climax in the mid twenties, and then wane over time (Grant, Dunne, Chesson, & Markowitz, 
2011).  Accordingly, HPV infections are most prevalent in college aged students, as sexual risk 
behaviors are deemed most prominent in this age group (Dunne, Unger, Sternberg,  McQuillan, 
Swan, Patel, et al, 2007; Grant et al, 2011; Revzina & DiClemente, 2005).  Sexually active 
females carry the highest rates of infection, with studies documenting rates as high as 68-71% in 
young, sexually experienced women (Kahn, Rosenthal, Jin, Huang, Namakydoust, & Zimet, 
2008; Smith, Melendy, Rana, & Pimenta, 2008; Villa, 2006).  Despite their elevated risk status, 
research has documented less than optimal knowledge about HPV (Gerend & Shepherd, 2011; 
Klug, Hukelmann, & Blettner, 2008; Waller, McCaffery, Forrest, & Wardle, 2004).  One recent 
study of 739 unvaccinated female students explored women’s familiarity with HPV-specific 
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information.  Gerend & Shepherd (2011) found heightened levels of awareness in this population 
of young women; in fact, nearly 100% reported some knowledge of HPV.  However, closer 
examination of the data highlighted important knowledge deficits; specifically, few could 
identify the multifarious outcomes of HPV infection (e.g., genital warts), and not many were 
privy to the risk of acquiring multiple infections by viral variants (Gerend & Shepherd, 2011).  In 
addition, nearly 40% of these women were still unable to identify HPV as an underlying causal 
agent of cervical cancer as well as acknowledge its status as a sexually transmitted infection 
(Gerend & Shepherd, 2011).   These findings are corroborated by other studies that find similar, 
low levels of factual HPV knowledge in young women (Ingledue, Cottrell, & Bernard, 2004; 
Dillard & Spear, 2010; Kobetz, Kornfield, Vanderpool, Finney Rutten, Parekh et al, 2010; 
Marek, Dergez, Bozsa, Gocze, Rebek-Nagy, Kricskovics et al, 2009), with the lowest rates 
documented in Taiwanese undergraduate women (Hsu, Cheng, Hsu, Fetzer, & Chou, 2011) and 
Hispanics (Fernandez, McCurdy, Arvey, Tyson, Morales-Campos, Flores et al, 2009; Ford, 
2011; Gerend & Shepherd, 2011; Jain, Euler, Shefer, Lu, Yankey, & Markowitz, 2009; 
Vogtmann, Harlow, Cruz Valdez, Cruz Valdez, & Lazcano Ponce, 2011).  Particularly 
noteworthy, researchers have found evidence for low HPV risk perceptions amongst women in 
spite of ongoing sexual activity, further highlighting disparities in HPV knowledge (Krawczyk, 
Perez, Lau, Holcroft, Amsel, Knauper et al, 2012).  Nonetheless, despite these discrepancies, 
young women who are highly educated, report more sexual partners, have a history of prior 
infection, and who learned of HPV through the media or a primary care physician evidenced 
greater HPV specific knowledge (Dillard & Spear, 2010; Gerend & Shepherd, 2011).   
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Interest and Uptake of Gardasil  
 The advent of HPV quadrivalent vaccines has provided women with a valuable tool to 
decrease their overall risk for cervical cancer.  Gardasil was approved by the Food and Drug 
Administration (FDA) in 2006 for use by women ages 9-26 as a primary cancer preventive tool, 
and efficacy studies have shown that it significantly reduces the acquisition of high risk viral 
strands implicated in the majority of the cases of cervical cancer (Cummings, Zimet, Brown, Tu, 
Yang, Fortenberry, & Shew, 2012; Herzog, Huh, Downs, Smith, & Monk, 2008; Villa, 2006).  In 
addition, the vaccine affords protection against viral strains that cause 90% of genital warts.  
Gardasil is delivered in a series of three, intramuscular injections over a span of 6 months, and it 
is postulated to confer its maximum protective function to HPV naïve individuals regardless of 
sexual status (American College of Obstetricians and Gynecologists [ACOG], 2010; Cummings 
et al, 2012; Lu, Kumar, Castellsaue, & Giuliano, 2011).   Naturally, the vaccine is directed at 
sexually inexperienced women as it is presumed they are less likely to have acquired one of the 
strains simulated in the vaccine (Villa, 2006).   
  Despite these recent advances, researchers continue to report inoculation rates that are 
often incomplete or inadequate (Medeiros & Ramada, 2011; Tan, Viera, Rowe-West, Grimshaw, 
Quinn, & Walter, 2011; Wong & Sam, 2010).  In fact, a recent report by the CDC asserts that 
Gardasil vaccination rates fall short when compared to other recommended vaccines (CDC, 
2011b).  One study of 428 women determined that only 19% of the sample received at least one 
of the three recommended doses of Gardasil (Manhart, Burgess-Hull, Fleming, Bailey, Haggerty, 
& Catalano, 2011).  Furthermore, among those who initiated, few (10%) completed the series 
and less than half of the remaining women reported intentions to get the final doses (Manhart et 
al, 2011).  In fact, HPV vaccination rates in young women are declining over time (Etter, Zimet, 
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& Rickert, 2012).   These findings are substantiated by other studies that also document 
substandard utilization of Gardasil among young adult women (Ford, 2011; Head & Cohen, 
2012; Jain et al, 2009; Vanderpool, Casey & Crosby, 2011).  Another retrospective study by Tan 
and colleagues (2011) further examined vaccination behaviors in a sample of 138,823 women 
aged 9-26.  While rates of vaccination were slightly higher in this sample (55%), most notable 
was their discovery of age-based differences related to Gardasil use.  Specifically, the 
researchers determined that women aged 18-26 were less likely to initiate and complete the 
series than those aged 13-17 (Tan et al, 2011).  Equally disconcerting, the researchers also 
discovered general noncompliance with inoculation guidelines, with only 28% of the sample 
completing the Gardasil series on time (Tan et al, 2011).  There is additional data highlighting 
important race-based disparities in vaccination behaviors; in fact, studies report that African 
American and Hispanic groups are less likely to initiate and complete the series (Cook, Zhang, 
Mullins, Kauf, Brumback, Steingraber et al, 2010; Niccolai, Mehta, & Hadler, 2011; Tan et al, 
2011).  Specifically, a recent study by Ford (2011) reported vaccination rates for White, Black, 
and Hispanic women aged 18-24 to be 23%, 8%, and 6%, respectively.  Further support for these 
age and race-based discrepancies is found in other exploratory studies (Head & Cohen, 2012; 
Jain et al, 2009; Liddon, Leichliter, & Markowitz, 2012; Taylor, Hariri, Sternberg, Dunne, & 
Markowitz, 2011).   
 Given the elevated risk of cervical cancer in women infected with HPV, researchers have 
endeavored to develop a general profile of women most amenable to HPV vaccination; however, 
the evidence delineating characteristics among those motivated to get vaccinated is variable.  
Several key factors have been associated with increased interest in getting the vaccine.  In 
general, studies have found that women who are White, unmarried, highly educated, have health 
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insurance, perceive vaccination behavior as socially acceptable, perceive themselves susceptible 
to acquiring HPV, perceive parental and physician support, endorse more positive attitudes, and 
are more well-informed about the vaccine typically express greater interest in getting vaccinated 
against HPV (Bendik, Mayo, & Parker, 2011; Conroy, Rosenthal, Zimet, Jin, Bernstein, Glynn et 
al, 2009; Dillard, 2011; Jain et al, 2009; Krawcyk et al, 2012; Liddon et al, 2012; Manhart et al, 
2011; Niccolai et al, 2011; Roberts, Gerrard, Rimer, & Gibbons, 2010; Vanderpool et al, 2011; 
Tan et al, 2011; Rosenthal, Weiss, Zimet, Good, & Vichin, 2011; Taylor et al, 2011; Tsau, 
Reutzel, Wang, Quinones, Nguyen, Hasan et al, 2011;  Zimet, Stupiansky, Weiss, Rosenthal, 
Good, & Vichnin, 2011).  Less consistent reports have linked drug use, marital status, prior 
experiences with Hepatitis B vaccine (Jain et al, 2009), fear of vaccine side effects, and low 
cancer risk perceptions to HPV vaccine acceptance  (Krawcyk et al, 2012; Manhart et al, 2011; 
Vanderpool et al, 2011; Zimet et al, 2011).  Of these factors, studies have predominantly found a 
role for vaccine knowledge in promulgating interest in getting vaccinated, especially if delivered 
by physicians (Zimet, 2005).  Vaccine cost has also been presented as a key obstacle to getting 
vaccinated, as Gardasil has been evidenced to be more expensive than other recommended 
vaccines (Gottlieb, Brewer, Smith, Keating, & Markowitz, 2009; McCave, 2010; Schwartz, 
Caplan, Faden, & Sugarman, 2007).   Yet, a recent study by Crosby, Casey, Vanderpool, Collins, 
& Moore (2011) concluded that more elusive factors may influence women’s decision to 
vaccinate.  In this study of 18-24 year old women living in Kentucky, Crosby & Colleagues 
(2011) distributed a series of vouchers that enabled women to access Gardasil for free.  Study 
findings determined that less than half the sample exchanged their vouchers for at least one dose 
of the vaccine; in particular, the majority of inoculations were most evident in urban sites where 
the vaccine was more readily available. The researchers concluded that vaccine accessibility 
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might have contributed to these findings, suggesting a role for motivational constructs.  
Appropriately, intentions to get vaccinate have been shown to influence vaccine uptake (Hopfer, 
2012; Manhart et al, 2011).  Lastly, other studies have found support for the role of self-efficacy 
in inciting HPV vaccine uptake (Hopfer, 2012).  Specifically, vaccine self-efficacy is speculated 
to increase confidence in one’s ability to overcome obstacles to getting the vaccine (Hopfer, 
2012).  In light of these findings, the data suggests that interventions created to stimulate vaccine 
interest in these high-risk groups should consider the complex interplay of internal and external 
factors that may drive the decision to vaccinate.   
 
Controversy Behind the Vaccine 
Clearly, the extant literature has illustrated the value of HPV vaccination in promoting 
cervical health.  Yet, despite these benefits, the emergence of this vaccine has elicited 
considerable controversy regarding its efficacy and impact on health care practices (Nelson, 
2007).  Fervent debate over the appropriateness of Gardasil vaccination initially arose in 
response to state mandates requiring young girls to be vaccinated prior to entering school 
(Schwartz et al, 2007).  Conservatives argued the movement was premature, citing its novelty as 
grounds for questioning its safety and utility (Hopfer & Clippard, 2011; Nelson, 2007; Schwartz 
et al, 2007).  Additional concerns emerged around the psychosocial implications of vaccination; 
specifically, opponents claimed that Gardasil may promote the message that hypersexual 
behavior is acceptable (Briones, Nan, Madden, & Waks, 2011; Ohri, 2007; Kollar & Kahn, 
2008).  Accordingly, studies document increased parental concerns over the possible false sense 
of security proffered by the vaccine (Ohri, 2007).  In addition to increased sexual risk behaviors, 
other critics contend that vaccination will decrease adherence to screening guidelines (Forster, 
Wardle, Stephenson, & Waller, 2010; Herzog et al, 2008).  Despite these concerns, investigators 
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exploring the impact of Gardasil vaccination on health behaviors report no discernible difference 
between vaccinated and unvaccinated women (Mather, McCaffery, & Juraskova, 2012).  On the 
contrary, vaccine completers have been evidenced to maintain safe sex beliefs and screening 
requirements in spite of vaccination status (Caskey, Lindau, & Alexander, 2009; Cummings et 
al, 2012; Doskoch, 2012).  Nonetheless, despite these findings, Gardasil continues to grow 
increasingly stigmatized as the public associates HPV infection and vaccination behavior with 
sexual promiscuity (Hopfer & Clippard, 2011).  
 
Information-Motivation-Behavioral Skills Model  
 There is a dearth of research investigating interventions that help stimulate Gardasil use 
among women.  Most of the interventions that exist have focused on using educational tools and 
pamphlets to enhance HPV, cervical cancer, vaccination knowledge, and vaccination attitudes 
amongst undergraduate women (Doherty & Graff Low, 2008), high school students (Gottvall, 
Tyden, Hoglund, & Larsson, 2010), and parents (Cox, Cox, Sturm, & Zimet, 2010), but few to 
date have examined the effectiveness of interventions in increasing vaccination rates, especially 
in high risk populations like undergraduate women.  Furthermore, even fewer interventions have 
been grounded in theory.  Only two known studies have developed interventions specifically 
targeting vaccine uptake, and results on vaccination rates were mixed.  Specifically, Patel, 
Zochowski, Peterman, Dempsey, Ernst, & Dalton (2012) determined that an HPV educational 
intervention coupled with a mailed reminder at 2 weeks was not successful in inducing vaccine 
uptake in a sample of undergraduate women when compared to a standard of care control group.   
Conversely, Hopfer (2012) reported success with a brief, peer and expert-led narrative 
intervention in increasing uptake, however the authors only measured vaccine initiation and not 
completion.  Moreover, their sample was older, consisting mostly of women beyond their first 
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year of college, and they demonstrated higher levels of HPV knowledge than found in other 
research (Hopfer 2012).  Lastly, they do not evaluate the impact of their intervention on other 
cervical cancer prevention behaviors.   
 Fisher and Fisher (1992) created the information-motivation-behavioral skills (IMB) 
model (see Figure 1) as a framework to understand and predict health behavior change.   Initially 
developed to elucidate the factors that influence HIV preventive behaviors, its use as a 
comprehensive, theoretically-based model has expanded to include a variety of populations and 
health behaviors, including diabetes care, breast cancer screening, and cardiovascular care 
(Osborn, Amico, Cruz, O’Connell, Perez-Escamilla, Kalichman et al, 2010; Fisher, Fisher, & 
Harman, 2003).  The IMB model maintains that information directly related to the target 
behavior, personal and social motivation to engage in the target behavior, and related behavioral 
skills to accurately execute components of the behavior are all essential precipitants to the 
performance of adaptive health behaviors (Fisher & Fisher, 1992; Fisher et al, 2003).  
Informational and motivational elements are proposed to be independent constructs that effect 
the implementation of health behaviors through their individual influence on behavioral skills; 
however, they may engender direct changes in behavior depending on the complexity of the 
behavioral skills.  Interventions founded on the IMB model address each of these integral 
components, which are based on preliminary investigation of the existing deficits in populations 
of interest.   
 Given the burden of HPV infections in this population and the unwavering link between 
HPV and cervical cancer, there is an emergent need for the development and testing of theory-
based interventions that directly support vaccine-seeking behaviors.  The purpose of this study 
was to examine the effectiveness of a theory-based, educational program to promote Gardasil use 
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among undergraduate women enrolled at the University of Connecticut.  In addition, a secondary 
goal of this study was to determine the intervention’s capacity to influence additional behaviors 
important for cancer prevention, including decreasing risky sexual behavior and engaging in 
regular pap smears for HPV detection.  It is hypothesized that 1) Women who complete the 
intervention will demonstrate greater improvements in knowledge, motivation, and behavioral 
skills related to vaccine use in comparison to women who complete the control group; 2) Women 
who complete the intervention will demonstrate greater behavioral intentions to pursue Gardasil 
vaccination in comparison to women in the control group; 3) Women who complete the 
intervention will demonstrate increased uptake of the HPV vaccine and increased practice of 
general cancer preventive behaviors, including increasing condom use and regular pap smears.  
The results of this study may help improve researchers’ understanding of factors that influence 
cervical cancer attitudes and vaccine uptake.  In addition, findings may help guide the 
development of a cost-effective, cancer prevention program that can be easily disseminated and 
implemented in health centers and university clinics.   
 
Methods 
Participants and Procedure 
 This study utilized a 2X3 randomized, controlled design to examine the effectiveness of 
an informational-motivational-behavioral skills based intervention in promoting Gardasil use.  
Specifically, this study incorporates a third time-point assessed one month post-baseline to 
explore behavioral changes consistent with cancer prevention and indicative of vaccine 
procurement.  Eligible participants were a convenience sample of women, aged 18-26 years, who 
were enrolled in an Introductory Psychology course at the University of Connecticut.  Students 
enrolled in these courses completed a set of university-wide screening measures prior to their 
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inclusion in the participant pool; those who completed the HPV vaccination series were excluded 
from the study.  Women interested in participating self-enrolled for a study session online via the 
university subject pool.  Study sessions scheduled on the pool calendar corresponded to either an 
active intervention or an attention control group; however, participants remained blind to study 
condition thereby preserving random group assignment.  During the initial session, subjects 
completed a consent form, filled out a baseline questionnaire battery, and then participated in 
either the control or experimental condition as scheduled.  Given the association between vaccine 
uptake and perceived social acceptance of Gardasil (Allen, Mohllajee, Shelton, Othus, Fontenot, 
& Hanna, 2009), the intervention was delivered in a small-group format to de-stigmatize HPV 
infection and normalize HPV vaccination.  To maintain equivalence between study conditions, 
the same design was utilized for the control subjects.  At the conclusion of the study session, 
participants completed a posttest questionnaire battery and were reminded of the one-month 
follow-up.   Approximately 4 weeks after the study baseline, participants were sent an email 
containing a link to a brief online survey.  All participants received research credit for 
participating in either or both study time-points as prearranged by their instructor.  Participants 
who completed the follow-up survey received a $5 card to the university Co-Op.  This study was 
reviewed and approved by the University of Connecticut Institutional Review Board.   
 
Experimental group.  Consistent with the IMB model, participants randomized to the 
educational intervention received information regarding cervical cancer, HPV infection and the 
HPV vaccine.  Women were first given a Gardasil information sheet that is readily available at 
the student health centers and online. Educational materials were presented with slides to address 
particular knowledge deficits that have been identified in this population based on a review of 
the literature (Allen et al, 2009; Bendik et al, 2011; Caskey et al, 2009; Daley, Vamos, Buhi, 
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Kolar, McDermott, Hernandez, & Fuhrmann, 2010).  In particular, participants were provided 
with information regarding the prevalence of HPV, methods of transmission, vaccine cost, 
safety, efficacy and specific side effects, and the importance of condom use.  A series of short 
video clips were presented to dispel popular myths associated with the HPV vaccine.  
Participants were encouraged to write notes and questions on the slide handouts provided at the 
beginning of the session, and the facilitator engaged the group in a discussion at the end of the 
informational section.    
  A second component of the intervention included the use of motivational interviewing 
techniques to enhance participants’ motivation to change their behavior, or in this case to get 
vaccinated.  Motivational Interviewing (MI; Miller & Rollnick, 1991) was utilized to address 
motivational components related to vaccine interest.  MI is a therapeutic style that focuses on 
building an empathic, nonjudgmental, and collaborative environment in efforts to build an 
individual’s self-efficacy and intrinsic motivation to change or practice a particular health 
behavior.  It is built on the premise that people are experts of their own selves, have a specific set 
of values that govern their behaviors, and are primarily responsible for inciting self-change 
(Emmons & Rollnick, 2006).  In accordance with the MI spirit, the entire intervention was 
delivered utilizing an air of acceptance, respect, and collaboration.  A discrete period 
emphasizing motivational strategies followed the informational portion of the intervention, at 
which point participants were asked to take 5 minutes to complete a decisional balance sheet 
identifying their personal pros and cons of getting vaccinated and highlighting 5 barriers to 
vaccination.  Following this task, participants separated into smaller groups of 2-3 to discuss 
their two lists.  After a brief, small-group discussion, participants were engaged in a larger group 
discussion and asked to list the top 3 pros, cons, and specific barriers for not getting vaccinated.  
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The facilitator wrote these barriers on the board and incorporated several core MI skills, 
including asking open-ended questions, providing affirmations, reflective listening, and 
providing summaries, to highlight instances of ambivalence and elicit self-change talk.  This 
segment ended with asking students to think about what it would take to get them to want to get 
vaccinated against HPV.   
 The final element of the intervention consisted of addressing behavioral skills related to 
accessing the HPV vaccine.  In particular, participants were provided with locations that offer the 
vaccine, sites where they can access additional information, questions they should ask their 
doctors, and questions they can ask their parents.  Given the literature’s emphasis on the role 
parental acceptance plays on vaccination intentions (Bartlett & Peterson, 2011), time was spent 
providing participants with ways to engage their family in their decision-making process.  In 
addition, participants were provided with strategies to promote vaccine acquisition and 
compliance with the 3 shot series; for instance, participants were directed to use phone, school, 
and gmail calendars to schedule appointments and set reminders.  Vaccine costs were discussed 
along with ways to access the vaccine if insurance coverage is a concern.  Additional related 
skills that were targeted included how to request and prepare for a pap screen, how often to get a 
pap screen according to current guidelines, and how to adopt healthier sexual practices including 
condom use.  Further tailoring of the intervention was undertaken by problem-solving any 
additional obstacles identified by the women during the general group discussion.    
 
 Control group.  Individuals randomized to the attention control group were given a 
Gardasil information sheet that is readily available at the student health centers and online.  In 
addition, to maintain consistency with the treatment’s presentation format, participants watched a 
set of short video clips encompassing aspects of women’s health and sexual health.  The videos 
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broadly covered topics related to what happens during a sexual health check, ways to improve 
access to health services, and methods of contraception.  Following the series of clips, 
individuals had the opportunity to engage in a brief group discussion and ask questions.  In 
response, they were directed to particular sections of the videos viewed or to websites readily 
available to the public.   
 
Measures  
Participants completed a questionnaire battery before and after completing the 
intervention or control group as well as one month later.  Scales that tap each of the model’s 
three dimensions were constructed by drawing questions from other studies of HPV and cervical 
cancer and modifying them to create an aggregrate measure that is consistent with instruments 
used in studies predicated on the IMB model.  The survey also consisted of a collection of 
questionnaires adapted from surveys used by the American Cancer Society and the National 
Cancer Institute that were readily available online.   The questionnaire battery assessed 
participants on a number of sociodemographic, personal and familial cancer history, sexual 
health behavioral practices, and general health behaviors.   Refer to Appendix A for the 
questionnaire used in this study.   
 
Primary Measures 
 Information. Consistent with studies based on the IMB model (Carey, Braaten, Maisto, 
Gleason, Forsyth, Durant, et al., 2000; Fisher, Fisher, Bryan, & Misovich, 2002; Fisher, Fisher, 
Misovich, Kimble,  & Malloy, 1996; Kalichman, Picciano, & Roffman, 2008; Osborn et al, 
2010), participants were assessed on their level of knowledge regarding information about HPV, 
the HPV vaccine, and cervical cancer.  Two questionnaires listed below were utilized to 
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determine individuals’ level of factual knowledge and “implicit beliefs” regarding Gardasil, 
HPV, and cervical cancer, as these have been demonstrated to influence the target behavior 
(Fisher et al, 2003).   
  HPV vaccine knowledge (Caskey et al, 2009). This scale is a 9-item series of true 
or false questions that measure women’s knowledge of the HPV vaccine.  Individual items are 
summed to arrive at a total scale score ranging from 0-9, and higher scores reflect greater 
vaccine-specific knowledge.  This questionnaire was developed and utilized in a study that 
measured young women’s knowledge and use of the HPV vaccine (Caskey et al, 2009).   
  Awareness of HPV and cervical cancer questionnaire (Ingledue et al, 2004).  
The Awareness of HPV and Cervical Cancer Questionnaire is a 40-item self report battery that 
measures two primary domains related to HPV and cervical cancer beliefs.  The first domain 
assesses knowledge of HPV and cervical cancer, and the second domain measures perceived 
threat of HPV and cervical cancer.  Perceived threat is further divided into two components:  
perceived seriousness and perceived susceptibility.  The knowledge dimension consists of 15 
factual questions about HPV and cervical cancer.  Participants are asked to select the best 
response out of 5 options for 5 multiple-choice questions (e.g., Cervical cancer can be diagnosed 
by...”), and then they are asked to identify risk factors for cervical cancer via a series of 10 true 
or false questions.  The number of correct responses is summed to obtain a total knowledge score 
ranging from 0-15, and higher scores demonstrate greater knowledge.  For the second dimension, 
perceived cervical cancer risk is determined by asking participants to rate their level of 
agreement with 9 statements (e.g., “I believe that I am at risk for cervical cancer”) on a 5-point 
Likert scale from 1 (strongly disagree) to 5 (strongly agree).  The nine individual items are 
summed to arrive at a total subscale score ranging from 9 - 45, and higher scores reflect greater 
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perceived susceptibility for cervical cancer.  This portion of the scale will be used as one of the 
five indices of motivation.  Lastly, the third subscale measures perceived seriousness by asking 
participants to identify their agreement with 6 statements (e.g., “All women who develop 
cervical cancer must have their uterus removed”) on a 5-point Likert scale from 1 (strongly 
disagree) to 5 (strongly agree).  Individual items are summed to arrive at a final subscale score 
ranging from 6-30, with higher scores indicative of greater perceived seriousness.  The internal 
consistency for each of the subdomains was fairly adequate, with ! = .70 for knowledge and ! = 
.76 for perceived susceptibility.  Internal consistency for perceived seriousness was quite low (! 
= .40).  Scale authors did not report internal consistency values in their review of the scale; 
however, the questionnaire was developed, utilized and validated in research with a college 
student population (Ingledue et al, 2004). 
 
 Motivation. Consistent with studies based on the IMB model (Carey et al., 2000; Fisher, 
et al, 2002; Fisher et al, 1996; Kalichman et al, 2008; Osborn et al, 2010), motivation to get 
vaccinated was assessed through five questionnaires to measure different aspects of motivation: 
perceived motivation, attitudes related to getting vaccinated, perceived social norms to getting 
vaccinated, behavioral intentions, and perceived risk for HPV/cervical cancer.   
  Motivation Self-Rating.  This self-report scale is a modified version of a scale 
used in Kalichman et al (2008).  Participants are asked to rank how motivated they would be 
from 1 (not at all) to 4 (very strong) to get the vaccine. Higher ratings denote greater levels of 
motivation to get the vaccine.  
  Attitudes toward getting vaccinated.  This self-report measure is a modified 
version of a scale used by Fisher and colleagues (1996).  Participants were asked to rate their 
agreement with seven behaviors related to getting vaccinated (e.g., getting more information 
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about HPV vaccine; getting the HPV vaccine in the next month; discussing HPV with friends) on 
three, 5-point Likert scales (e.g., good-bad, nice-awful, pleasant-unpleasant).  These items were 
summed to create a final measure of attitudes toward getting vaccinated ranging from 21-105, 
with higher scores denoting more negative attitudes.  The internal consistency for this measure 
was high (! = .95) and consistent with other studies (Fisher et al, 1996).   
   Perceived social norms.  This scale was also modeled after a measure of social 
norms used by Fisher and colleagues (1996).  Participants’ perception of social convention 
related to getting vaccinated was assessed by asking participants to rate their agreement with 
seven behaviors associated with getting vaccinated (e.g., getting more information about HPV 
vaccine; getting the HPV vaccine in the next month; discussing HPV with friends) on a 5-point 
Likert scale (very untrue to very true).  Scale items were summed to arrive at a final measure of 
perceived social norms ranging from 7-35; higher scores reflect greater perceived social norms.  
The Cronbach’s alpha for this scale (! = .91) was consistent with Fisher et al’s (1996) measure 
used in other college populations.   
  Behavioral intention.  Participants were asked a set of 7 questions about their 
intentions regarding getting more information about the vaccine, discussing the HPV vaccine 
with their friends, and actually getting the HPV vaccine within the next year and/or within the 
next 3 years.  The first question specifically asks participants about their commitment to getting 
vaccinated in the next year, and response options included “undecided”, “I do not want to get the 
vaccine”, and “I want to get the vaccine.”  For the purposes of analysis, these responses were 
reordered to reflect contemplative movement, with “I do not want to get the vaccine” categorized 
as 0, “undecided” as 1, and “I want to get the vaccine” as 2.  For the remaining six questions, 
participants were asked to rate their intentions to engage in each of the vaccine-seeking 
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behaviors on a 6 point Likert scale, from 1 (very unlikely) to 6 (very likely).  This scale was 
modeled after a study aimed to reduce AIDS risky behavior in a college student population 
(Fisher et al, 1996), and questions were drawn from a measure used in Gerend, Lee & Shepherd 
(2007) to assess personal acceptability of the HPV vaccine.  The seven items were summed to 
arrive at a final score ranging from 6 to 39.  Higher scores reflect greater intentions to get the 
HPV vaccine.  The internal consistency (! = .89) for this scale is concordant with that found in 
Fisher and colleagues’ (1996) college student population.   
 
 Behavioral skills. Consistent with studies based on the IMB model (Carey et al., 2000; 
Fisher et al, 2002; Fisher et al, 1996; Kalichman et al, 2008; Osborn et al, 2010), participants’ 
belief and confidence in their ability to get vaccinated were assessed.  
  Perceived efficacy.  Modeled after Fisher and colleagues (1996), participants 
were asked to rate how effectively they would be able to carry out nine behaviors associated with 
getting vaccinated (e.g., how effectively can you get vaccinated completely against HPV; how 
effectively can you find the time to go to your health provider for three visits to get vaccinated 
against HPV; how effectively are you in affording to get vaccinated against HPV, etc) on a 5-
point Likert scale.  Response options included 1 (very ineffectively) to 5 (completely 
effectively), and the scale was averaged to arrive at a final scale score ranging from 1 to 5.  
Higher scores reflect greater perceived skills to get vaccinated, and Cronbach’s alpha was high 
(! = .86). 
  Perceived difficulty.  Consistent with Fisher et al (1996), participants were asked 
to rate their perceived difficulty from 1 (very hard to do) to 5 (very easy to do) in carrying out 
nine behaviors associated with getting vaccinated  (e.g., how difficult would it be to get 
vaccinated completely against HPV; how difficulty would it be to find the time to go to your 
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health provider for three visits to get vaccinated against HPV; how difficult would it be to afford 
to get vaccinated against HPV, etc).  Scale items were averaged to create a final score, with 
higher values indicative of greater perceived barriers.  This measure demonstrated good internal 
consistency for this study (! = .83).   
 
 Cervical cancer preventive behaviors.  Participants were asked a series of 9 yes/no 
questions to explore performance of several key cervical cancer preventive behaviors, including 
taking steps to get screened and taking steps to learn more about or access the HPV vaccine, at 
two time-points (i.e., pre-intervention and one-month follow-up).  One question inquired about 
frequency of condom use on a 7-point Likert scale, with response options ranging 0 (not 
applicable) to 6 (always).  For the purposes of analyses, individuals who responded to this 
question as not applicable and thus not sexually active were considered as engaging in sexually 
protective behavior; henceforth they were grouped into the category identified as 
frequent/always condom use.   Prior to analysis, this question was further categorized by 
collapsing response options into three, increasing categories: none to rare condom use (0-points), 
occasional condom use (1-point), and frequent condom use/not sexually active (2-points).  All 
ten items were then summed to arrive at a final cancer preventive score ranging from 0-11.  
Higher scores are consistent with greater endorsement of more cancer preventive behaviors.  A 
final question asks participants to identify reasons for not getting vaccinated.   
 
Secondary measures  
 Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS; McRee, Brewer, 
Reiter, Gottlieb, & Smith, 2010). The CHIAS is a 16-item self-report measure evaluating 
beliefs and attitudes towards the HPV vaccine.  Although the scale was developed and primarily 
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used in studies with parent populations, the authors provide suggestions regarding scale revisions 
for utilization with other populations (McRee et al, 2010).  The scale contains questions that 
assess four dimensions related to vaccine attitudes, including perceived harm (e.g., “The HPV 
vaccine might cause lasting health problems”), barriers (e.g., “I am concerned the HPV vaccine 
costs more than I can pay”), effectiveness (e.g., “How effective do you think the HPV vaccine is 
in preventing genital warts”), and uncertainty (e.g., “I don’t have enough information about the 
vaccine to decide whether to get it”). Twelve items are rated on a four-point scale from 1 to 4, 
with unique anchor points (e.g., strongly disagree to strongly agree or slightly effective to 
extremely effective) assigned to individual items.   Four of the items are rated on a three-point 
scale (i.e., not hard at all to very hard).  Higher scores within each subscale are indicative of 
stronger agreement, with summary scores ranging from 6-24 for the Perceived Harm subscale, 5-
20 for Perceived Barriers, 2-8 for Perceive Effectiveness, and 3-12 for Perceived Uncertainty.  
Internal consistency for each of the subscales is adequate (! = .61-.69) and consistent with what 
was found in this study for the perceived harm and perceive barriers subscale (! = .73).  Internal 
consistency was very low for the Effectiveness and Uncertainty subscale (! = .42 and ! = .50, 
respectively).  Survey developers also reported a relationship between vaccination intentions and 
each of the CHIAS subscales. 
 
Data Analysis 
  SPSS version 20.0 was used to conduct all statistical analyses for this study.  Prior to 
data analysis, all of the data was screened for missing information and for violations of 
normality.  Although some of the data were not consistent with a normal distribution, 
transformation of the scores did not influence study outcomes.  Furthermore, transformation 
techniques are no longer generally recommended, especially when the tests used are 
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predominantly robust by design (Field, 2009).  Accordingly, the remainder of analyses was 
conducted on original data.  
 Descriptive statistics, including frequencies, means, and ranges, were performed to 
describe the sample. Knowledge, motivation, and behavioral skills were assessed at baseline, 
post-intervention and at one-month follow-up, and behavior change was assessed at the one-
month follow-up.  Group equivalence on baseline IMB constructs was established using T tests 
(continuous) and Chi squares (categorical); similarly, T tests and Chi square analyses were used 
to test for mean differences on relevant baseline psychosocial factors.  As recommended by Field 
(2009), only baseline differences that are significantly correlated with each outcome of interest at 
p < .05 were included as covariates for related tests.  Baseline differences were discovered for 
age and prior pap test history.  In addition to these covariates, prior vaccination status was added 
as a covariate across all statistical tests given its statistical and theoretical relationship with most 
of the study outcomes.  Similarly, insurance status was added as a covariate for tests of group 
differences in behavioral skills given its potential impact on perceived obstacles and ability to get 
vaccinated. 
 A series of 2X3 repeated measures analysis of covariance (ANCOVA) were used to 
examine mean differences between groups on each of the composite factors of the IMB model: 
1) knowledge, 2) motivation, and 3) behavioral skills.  A multivariate analysis of covariance 
(MANCOVA) was used to assess for group mean differences in the motivational construct given 
the fact that the 5 scales used were highly correlated.  This statistical test was used only for the 
motivational index given the number of scales that comprise this factor, and studies suggest that 
MANCOVA is helpful controlling for type 1 error and for accounting for the correlations among 
these factors (Doherty & Graff Low, 2008).  Post hoc independent sample T tests and/or pairwise 
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T tests were used to further explore significant group differences at each of the time-points.  
When post-hoc tests were conducted, the Family Wise Error Rate (FWE) was controlled for by 
adjusting the significance level to p = .025 (i.e., .05/2 comparisons).  Multivariate linear 
regression analyses were used to determine significant predictors of vaccine acceptability.  
Demographic variables theoretically and significantly associated with all of the IMB indices, 
including age and prior HPV vaccination history, were entered into the regression analysis as one 
block, and scales corresponding to each of the model’s constructs were entered together as a 
second block.  All statistical tests were two-tailed, and the significance level for all tests was set 
at p < .05.   
Results 
 
Characteristics of the Sample  
Table 1 details the demographic information for the whole sample.  A total of 70 women 
participated in the study.  Of the 70 participants, 62 (89%) fully completed the one-month 
follow-up survey.   Two thirds of the sample were Caucasian, and about 21% self-identified as 
Hispanic.  Their mean age was 19 years (range, 18-26), and 75% were in their freshman (48.4%) 
or sophomore (25.8%) year of college.  About half of the respondents reported that they were 
either employed part-time during the school year or over the summer, and the remainder of the 
participants did not work.  Family income was relatively high among respondents, with a little 
over half reporting an income bracket greater than $75,000. 
Health and health behaviors.  Tables 2 and 3 provide general health information and 
cervical cancer risk behaviors for the sample. The majority of the participants were insured 
(92.9%), and they reported having a regular physician (87.1%).  Approximately half of the 
women perceived themselves to be very healthy; only 11.3% identified having a significant 
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medical condition which consisted of a past cancer diagnosis (acute lymphoblastic leukemia), 
Hepatitis C, Crohn’s Disease, chronic renal disease, and polycystic ovarian syndrome.  More 
than half of the women (59.7%) reported a positive familial history of cancer, but none reported 
any personal or family history of cervical cancer.  A large proportion of the sample engaged in 
healthy lifestyle behaviors, with approximately 72.6% reporting regular exercising, 90.3% 
denying any drug use, and only half (51.6%) engaging in some alcohol use.  Specifically in terms 
of cervical cancer screening behaviors, less than a third (27.4%) reported ever having had a pap 
screen.  Among the 17 women who have ever had a pap test, the majority (88.2%) initiated 
screening when they were 16-19 years old and about 64.4% reported having been screened 
within the past six months to one year.   
Cervical cancer-specific behaviors and risk factors.  The current sample was 
predominantly sexually active (59.7%), with 1.6% first initiating sex as early as age 12, 34.4% 
between the ages of 15-17, and 38.8% initiating sexual activity beyond age 18 (refer to table 3 
for a summary of cervical cancer-specific behaviors).  Among those who were sexually active, a 
majority (64.9%) were in a monogamous, romantic relationship; a slightly larger proportion 
(73%) reported having had only one sexual partner over the past year, and the remainder (21.6%) 
reported having had more than 2 romantic partners.  Only a small sample of women (8.1%) 
reportedly had more than 5 sexual partners over the past year.  The number of lifetime sexual 
partners was slightly higher in this group; specifically, fewer than half indicated having only 1 
lifetime sexual partner, 32.4% reported 2-4 lifetime sexual partners, and 21.6% identified as 
having had more than 5 sexual partners in their lifetime.  Despite their sexual history, the sample 
predominantly engaged in safer sexual behaviors.  About 75.6% of the women reported frequent 
use of condoms, and only 8.1% and 10.8% reportedly using condoms “sometimes” or “rarely”, 
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respectively.  Accordingly, rates of sexually transmitted infections were low, with only 3.2% 
identifying a history of Chlamydia infection.  Similarly, few (4.8%) reported ever receiving an 
abnormal pap test result.  In terms of other behaviors associated with increased risk of cervical 
cancer, few participants reported oral contraceptive use (22.6%) and fewer reported having ever 
smoked (21%).    
 Awareness of HPV and Gardasil.  Refer to table 4 for a summary of knowledge and 
experience with HPV and Gardasil.  The majority of the sample reported having heard about 
HPV (87.1%), though few (8.1%) had actually undergone testing for HPV.  Relatedly, a 
considerable number of women reportedly had heard of the Gardasil vaccine (79%).  Despite 
their general awareness, nearly 77.4% of the sample considered themselves as having limited 
knowledge about the vaccine, 17.7% admitting knowing nothing at all, and only 16.1% had 
actually received at least one dose of the vaccine.  The most popular medium through which 
individuals first learned about the vaccine was via the television (50%), a friend (35.5%), and 
through a non-PCP physician or nurse (33.9%).  Few reportedly heard about the vaccine through 
their PCP (27.4%), gynecologist (22.5%), and family (25.8%); however, a large proportion of the 
sample (83.9) demonstrated a preference for learning about the vaccine from their primary care 
doctor.  Despite this preference, less than a quarter of the women were advised to get the vaccine 
by their gynecologists, and only half (56.5%) received vaccine recommendations by their PCP.   
 Knowledge of HPV and Gardasil.  Tables 5 and 6 provide a summary of women’s 
knowledge of HPV and Gardasil.  By and large, a majority of the women demonstrated a 
considerable amount of knowledge of facts related to the Gardasil vaccine.  Specifically, all of 
the participants correctly believed that women who were vaccinated must continue to use 
condoms during sex, and a large proportion correctly assumed that the vaccine does not protect 
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against all STDs (96.8%).  Similarly, the majority disagreed with the belief that vaccination 
precludes individuals from requiring pap tests (98.4%) and reduces the need for regular pelvic 
exams (91.9%).  Notably, fewer women erroneously believed that women who get the vaccine 
can worry less about getting STDs (83.7), and even fewer demonstrated an awareness that HPV 
protects against cervical cancer (71%).   
 While general knowledge of Gardasil was high, women demonstrated poorer factual 
knowledge of details related to HPV.  Particularly, the participants in the study were most 
misinformed about factors that increase risk for cervical cancer.  Specifically, a very small 
proportion of the sample recognized that smoking (12.9%) and oral contraceptives (4.8%) 
increase risk for cervical cancer, and only 9.7% correctly believed that genital warts do not 
increase risk for cervical cancer.  Similarly, less than half of the sample knew that drugs (41.9%) 
and diet (45.2%) is not related to cancer risk while having sex before 18 increases one’s 
susceptibility for cervical cancer (45.2%).  In addition, only 48.4% were aware that HPV 
infection can remain latent without symptoms, and fewer (40.3%) correctly assumed that HPV 
causes genital warts.  Despite these general knowledge deficits, more women seemed to 
understand the sexual nature of HPV.  Specifically, a sizable proportion were aware that HPV is 
sexually transmissible (75.2%) and that HPV is associated with cervical cancer (71.0%).   
Accordingly, many believed that having multiple sexual partners (77.4%) and contracting any 
sexually transmitted diseases (71.0%) can increase one’s risk for cervical cancer while tampon 
use does not increase cancer risk (71.0%). In the same vein, approximately 74.2% of the women 
correctly believed that celibacy, pap tests, and condom use are all effective methods for 
preventing cervical cancer (74.2%).   
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Intervention Effects on Information, Motivation, and Behavioral Skills 
 Information.  A repeated measure ANCOVA was utilized to assess for group differences 
in mean knowledge scores across all three time-points after adjusting for age, pap test 
experience, and vaccination status.  Mauchly’s Test of Sphericity was significant for the main 
effect of time ("2 (2) = 8.438, p = .02) indicating that the assumption of sphericity was not met, 
so a Greenhouse-Geisser correction was applied.  A repeated measures ANCOVA indicated a 
significant group by time effect for total HPV and Gardasil knowledge scores, F(1.76, 5.90) = 
4.69, p = .015.  This indicates that differences in total knowledge scores between conditions 
depended on time. A polynomial contrast revealed a significant linear trend, F(1,57) = 8.38, p = 
.005.  To breakdown this interaction, a series of contrasts were performed comparing knowledge 
scores for both conditions at each time-point.  A simple effects contrast comparing knowledge 
scores for each group at pretest and posttest revealed a marginally significant difference, F(1, 57) 
= 3.984, p = .051.  An examination of Figure 2 and adjusted group means shows that although 
both conditions experienced an increase in knowledge scores from pre- to post test, there was a 
greater increase in knowledge scores for participants in the experimental group compared to 
participants in the control condition.   Accordingly, post hoc t-tests suggests that knowledge 
scores at posttest showed a marginally significant difference after controlling for the Familywise 
Error Rate (p = .025), t(60) = -2.235, p = .029).  Conversely, a second contrast measuring group 
differences from posttest to follow-up yields no significant difference, F(1, 57) = .514, p = .476; 
however, post hoc t-tests suggests that knowledge scores were significantly different at the one-
month follow-up,   t(60) = -4.482, p < .001.  A glance at Figure 2 and adjustment group means 
suggests that although there were no significant changes in knowledge scores from posttest to 
follow-up across conditions, women who participated in the experimental condition were likely 
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to maintain a higher level of knowledge of HPV and Gardasil after one month; in contrast, 
participants in the control condition demonstrated a nonsignificant decline in knowledge levels.    
 Additional repeated measures ANCOVAs were conducted for the individual measures 
(i.e., total vaccine knowledge and knowledge of HPV and cervical cancer) used to arrive at the 
total knowledge score.  Mauchly’s Test of Sphericity was not significant for the main effect of 
time ("2(2) = 3.953, p > .05) indicating that the assumption of sphericity was met.  A repeated 
measures ANCOVA for vaccine knowledge revealed a significant interaction effect, F(2, 114) = 
3.876, p = .024.  A polynomial contrast revealed a significant linear trend, F(1,57) = 6.74, p = 
.012.  Simple effects contrasts for pretest and posttest showed that vaccine knowledge increased 
equally for both groups, F(1,57) = .000, p = .991; similarly, post-hoc t-tests showed there were 
no significant group differences at the post-test, t(49.28) = 1.81, p = .076.  Conversely, simple 
effects contrasts for posttest and follow-up demonstrated a significant interaction at follow-up 
F(1,57) = 4.589, p = .036.  Specifically, while vaccine knowledge scores continued to increase at 
follow-up for women in the experimental group, they decreased for participants in the control 
condition. Closer examination of scores at follow-up via post hoc t-tests suggests the group 
differences in vaccine knowledge were not significant, t(49.39) = -1.530, p = .132.  Looking at 
Figure 3, this suggests that vaccine knowledge significantly and steadily increased across time-
points for participants in the experimental group; in contrast, while vaccine knowledge increased 
from pretest to posttest for the control condition, vaccine knowledge significantly decreased over 
the follow-up period.   
 A third set of repeated measures ANCOVA was conducted for the measure of HPV and 
cervical cancer knowledge.  Mauchly’s Test of Sphericity was significant, "2(2) = 9.975, p = 
.007, suggesting that the assumption of sphericity has been violated; as a result, a Greenhouse-
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Geisser adjustment was applied.  Results of the repeated measures ANCOVA indicated a 
significant group X time interaction for HPV and cervical cancer knowledge, F(1.72, 98.00) = 
4.33, p = .02.  A polynomial contrast revealed a significant linear trend, F(1,57) = 6.14, p = .016.  
Closer examination of these results by looking at Figure 4 and simple effects analyses for pretest 
and posttest knowledge scores suggest that participants in the experimental group showed more 
pronounced increases in knowledge scores compared to the control group, F(1,57) = 4.93, p = 
.03.    Post hoc t-tests showing significant group differences at posttest verified these results even 
after controlling for the Familywise Error Rate, t(60) = -2.93, p = .005.  A second simple effects 
analysis demonstrates a similar increase in knowledge scores from posttest to the one-month 
follow-up regardless of condition, F(1,57) = .00, p = .99; however, post-hoc t tests reveal 
significant group differences at the follow-up, t(60) = -4.74, p < .001. Together, these results 
suggest that compared to the control group, participants in the experimental group demonstrated 
greater increases in knowledge of HPV and cervical cancer factual information at posttest, and 
this level of knowledge was maintained through follow-up leading to sustained group 
differences.   
 
  Motivation.  Adjusting for age and vaccination status, a two-way, repeated measures 
MANCOVA was conducted to determine the effect of condition on all 5 motivation constructs 
across time.  A significant group by time interaction was revealed, Pillai’s Trace (10, 47) = .509, 
p < .001.  Univariate ANCOVAs on each of the indices that compose the motivation construct 
are reported as follow-up tests, and tests were appropriately adjusted with Greenhouse-Geisser 
when Mauchly’s test of Sphericity was violated.  Mauchley’s test of Sphericity was violated for 
intent, "2(2) = 7.16, p = .03,  attitudes, "2(2) = 7.18, p = .03, and perceived social norms, "2(2) = 
22.35, p < .001.  Significant group by time interactions were found for self-reported motivation,  
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F(2, 112) = 4.16, p = .018,  Intention, F(1.78, 99.82) = 7.40, p = .002, Attitudes, F(1.78, 99.79) = 
7.11, p = .002, and perceived susceptibility, F(2, 112) = 3.126, p = .048.  There was no 
significant interaction or main effect of time or group for perceived social norms (p = .45).   
Examination of Figure 5 in the context of simple contrasts comparing groups on self-reported 
motivation revealed that the experimental group had a more pronounced increase in self-reported 
motivation from pretest to posttest, F(1, 56) = 7.66, p = .008.  On the other hand, a second 
contrast of posttest and follow-up scores showed that each condition experienced a similar 
decline in perceived motivation from posttest to follow-up, F(1,56) = .364, p = .548.  Bonferroni 
adjusted post hoc t-tests revealed no significant group differences in perceived motivation at 
posttest, t(54.86) = -1.53, p = .131, or at follow-up t(60) = -.813, p =.42.  As is evident in Figure 
5, these results suggest that although both groups evidenced an increase and subsequent decrease 
in motivation across all three time-points, the experimental group experienced a more 
pronounced increase in self-reported motivation from baseline to follow-up; however, these 
differences were not sustained at follow-up and instead declined along with the control group.  
Figure 6 displays group changes in intention to get vaccinated across time-points.  To break 
down the interaction effect for self-reported intentions, a set of simple contrasts were performed 
comparing both groups at each time-point. The first contrast looking at intention scores from 
pretest to posttest revealed significant results, F(1,56) = 19.05, p <.001. Examination of Figure 6 
and adjusted group means shows a more pronounced increase in intentions scores from pretest to 
posttest for participants in the experimental group; accordingly, post hoc t-tests revealed 
significant group differences in intentions to get vaccinated at posttest, t(51.11) = -2.23, p = .03.  
A second contrast comparing groups across follow-up found that both groups experienced a 
decrease in intentions from posttest to follow-up, but the decline was more pronounced for 
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members of the experimental condition, F(1,56)=8.18, p = .008.  Post hoc t-tests found no 
significant group differences at follow-up (p = .807).  These findings suggest that intentions 
scores increased significantly for experimental participants immediately following the 
intervention, however they declined just as quickly over the one-month period. 
 Similarly, the interaction effect for attitudes toward Gardasil vaccination was broken 
down with a series of contrasts.  Figure 7 displays change in attitudes toward Gardasil 
vaccination across all three time-points.  The first contrast investigated group differences in 
attitudes between pretest and posttest.  This contrast determined that the experimental group 
displayed a more pronounced decrease in negative attitudes toward Gardasil vaccination, F(1,56) 
= 19.41, p <.001.  A significant group difference in attitudes at posttest was verified by 
Bonferroni corrected post hoc t-tests, t(48.69) = 2.80, p = .007.  Despite this decrease, a second 
contrast determined that women in the experimental also experienced a pronounced increase in 
negative attitudes from posttest to follow-up, F(1,56) = 5.63, p = .02.  Post hoc analyses for the 
follow-up showed no significant group differences in attitudes at this time-point, t(51.28) = .93, 
p = .36.  Together, these findings suggest that the experimental manipulation led to immediate 
improvements in attitudes toward Gardasil vaccination following the intervention, however these 
improvements were not sustained over one month.  There were no significant changes in 
attitudes for individuals in the control group.  
 Figure 8 displays changes in social norms related to getting vaccinated.  Perceived social 
norms for vaccination revealed no significant trends or group differences in scores across time-
points (p >.05).  Inspection of Figure 8 shows that at first both groups experienced an increase in 
social norms associated with getting vaccinated from pretest to posttest, and subsequently scores 
declined at follow-up for both conditions.  A look at the adjusted means suggests that the decline 
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in perceived social norms was most prominent for participants in the control group, however this 
difference was not significant. 
 Figure 9 displays changes in perceived risk for HPV and cervical cancer across time. The 
first contrast examining group change from pretest to post test was nonsignificant,  F(1,56) = 
2.94,  p = .092,  suggesting that both groups experienced a similar increase in perceived risk 
scores at the end of the experiment; however, adjusted group means suggests that the 
experimental group experienced slightly increased risk perceptions following the manipulation.  
Contrasts for the posttest to follow-up revealed a significant interaction effect, F(1,59) = 6.42, p 
= .014.  Bonferroni corrected post hoc t-tests revealed significant group differences only for the 
posttest period, t(60) = -2.861, p = .006.   As depicted in Figure 9, these results suggest that the 
experimental group experienced an increase in HPV and cervical cancer susceptibility 
immediately following the intervention, however this risk perception declined over the one-
month period.  In contrast, there were no significant changes in perceived risk for HPV and 
cervical cancer in the control group. 
 
 Behavioral skills. A two-way, repeated measures MANCOVA adjusting for age, 
insurance status, and HPV vaccination status was conducted to determine the effect of condition 
on both indices of behavioral skills, and no significant main or group interactions were detected 
(p > .05).  Despite these null results, univariate ANCOVAs were further examined to identify 
any significance in the individual constructs.  Tests were appropriately adjusted using 
Greenhouse-Geisser when violations of sphericity occurred as indicated by Mauchley’s Test of 
Sphericity.  Analyses for perceived self-efficacy to get vaccinated revealed no significant main 
or interaction effects (p > .05).  Although not significant, a trend analysis was conducted to 
examine potential trends in the data.  Accordingly, a significant quadratic trend was found for the 
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interaction effect,  F(1,57) = 4.487, p = .039.  This trend is displayed in Figure 10.  Specifically, 
perceived efficacy increased significantly from pretest to posttest for the experimental group, but 
then it dropped significantly from posttest to follow-up.  In contrast, scores for the control group 
steadily increased across time.  Post hoc analyses at each time-point revealed no significant 
group differences posttest or at the one-month follow-up (p > .05). These findings suggests that 
the IMB intervention may be more effective in increasing self-efficacy in the experimental group 
in the short term, however these changes are not sustained over the one-month follow-up.   
 Univariate analyses for perceived difficulty were also examined.  As indicated, tests were 
appropriately adjusted using Greenhouse-Geisser when violations of sphericity occurred as 
indicated by Mauchly’s Test of Sphericity.  Similar to perceived self-efficacy, there were no 
main or interaction effects for perceived difficulty (p>.05).  In addition, there were no significant 
trends in the data (p>.05).  As indicated in Figure 11, ratings of perceived difficulty (or rather 
feasibility) appeared to increase from pretest to posttest regardless of condition; however, ratings 
decreased from posttest to follow-up for both groups.  Examination of adjusted means in 
conjunction with Figure 11 suggests that the experimental group experienced a more pronounced 
increase in perceived feasibility to get vaccinated from pretest to posttest; however, these beliefs 
declined to baseline rates by the one-month follow-up.  These changes were not significant.   
 
 Behavioral Intentions.  There was a significant association between group and 
intentions to get vaccinated "2 (2) = 6.88, p = .032.  This suggests that participants in the 
experimental group were more likely to report wanting to get vaccinated at the one-month 
follow-up compared to participants who participated in the control group.  Based on the odds 
ratio, the odds of wanting to get vaccinated were 7.69 times higher if women participated in the 
experimental group compared to the control group.  In addition, intentions to engage in 
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additional behaviors related to getting vaccinated demonstrated a significant relationship with 
group status, "2 (1) = 6.61, p = .01.  Women in the experimental group were 6.90 times more 
likely to report intentions to engage in vaccination-seeking behaviors compared to women in the 
control condition.  Lastly, there was a significant relationship between group status and 
intentions to get pap smears in the future "2 (2) = 15.84, p = .003.   Based on the cross-tabulation 
table, women who participated in the experimental group were more 26.13 times more likely to 
anticipate getting a pap screen every two years, as recommended by CDC (2012); conversely, 
women in the control group were 4.93 times more likely to anticipate getting yearly pap tests. 
There were no group differences in intentions to get vaccinated, get pap smears, or engage in 
vaccine-seeking behaviors at baseline and the one-month follow-up (p>.05).   
 
Cervical Cancer Preventive Behaviors   
 Mean differences in the aggregate set of behaviors associated with cancer prevention 
were examined with independent t-tests.  There were no significant differences between groups 
in terms of behaviors performed at baseline, t(60) = .000, p = 1.00, and at the one-month follow-
up, t(60) = -.140, p = .89.  However, mean differences in behaviors within groups were examined 
at baseline and follow-up using paired-sampled t-tests.  On average, women who participated in 
the experimental group endorsed more cancer prevention behaviors at follow-up (M = 2.87, SE = 
.29) compared to baseline (M = 2.19, SE = .24).  This difference was significant t(30) = -2.39, p 
= .023, and it represents a medium-sized effect r = .38.  Conversely, women who participated in 
the control group did not demonstrate a difference in cancer preventive behaviors from baseline 
(M = 2.19, SE = .17) to follow-up (M = 2.81, SE = .36), t(30) = -1.84, p = .076.  These results 
suggest that women in the experimental group demonstrated a significant, positive change in 
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cancer prevention behaviors as compared to women in the control condition, although at follow-
up the differences between the two groups were not significant. 
 Group differences for each of the individual behaviors associated with cancer prevention 
were examined with contingency tables using Chi Square tests.  There were no significant 
differences between groups at baseline or at the one-month follow-up for behaviors related to 
accessing more information about Gardasil, discussing Gardasil with family, friends, or doctor, 
scheduling an appointment to begin the HPV vaccination series, initiating the vaccine series, 
condom use, scheduling a pap smear, or getting a pap test (p > .05).   
 
Predictors of cervical cancer preventive behaviors 
 A hierarchical multiple regression analysis was conducted to evaluate how well the IMB 
theoretical model predicts overall cervical cancer preventive behaviors after adjusting for age 
and vaccination status.   Table 7 shows a summary of the regression analysis. At step 1, none of 
the demographic variables were significantly associated with preventive behaviors; however, 
adding each of the IMB indices to the second step resulted in a significant F change statistic, 
F(8,51) = 6.43, p < .001.  Accordingly, the IMB model accounts for 50% of the variance in 
cancer preventive behaviors, R2 = .50, R2 = .50, adjusted R2 = .41, and the overall regression 
equation is statistically significant (F[10, 51] = 5.17, p < .001).  Close examination of the 
individual variables suggests that not all variables are equally important in this model.  In fact, 
perceived susceptibility (b = -.10, B = -.31, p = .011) and prior vaccination initiation (b = -1.79, 
B = -.37, p = .005) had a statistically significant effect on preventive behaviors.  These findings 
suggest that  each one standard deviation increase in perceived susceptibility led to a .31SD 
decrease in cancer preventive behaviors.  Similarly, each standard deviation increase in prior 
vaccination status led to a .37SD decrease in cancer preventive behaviors.   
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Secondary Analyses 
 
Attitudes toward vaccination.  Adjusting for age and vaccination status, a series of two 
way, repeated measure ANOVAs were conducted to examine group differences in each of the 
four dimensions of general attitudes toward the HPV vaccine as measured by the CHIAS.  Tests 
were appropriately adjusted with Greenhouse-Geisser when Mauchly’s test of Sphericity was 
violated.  Mauchley’s test of Sphericity was violated for perceived harm, "2(2) = 6.86, p = .03 
only, and analyses investigating group differences in perceived vaccine harm across time-points 
found a significant interaction effect, F(1.80, 104.18) = 9.37, p <.001.  Contrasts conducted to 
further delineate group differences determined that the experimental group displayed a 
prominent decrease in perceived vaccine harm from pretest to posttest, F(1,58) = 20.25, p < .001; 
however, ratings did not significantly change from posttest to follow-up for either condition, 
F(1,58) = .171, p = .68.  Accordingly, Figure 12 shows that for the control group, perceived harm 
associated with getting vaccinated remained relatively stable across time-points.  In contrast, 
perceived harm decreased significantly immediately following the intervention for participants in 
the experimental group, and these differences were maintained at the one-month follow-up.  
Figure 13 shows changes in ratings of perceived barriers to getting vaccinated across time-points, 
and a two way repeated measures ANOVA revealed no significant main effects for time, group, 
or the interaction as well as no significant trends.  As depicted in Figure 13, perceived vaccine 
barriers declined for both conditions immediately following the experiment, and they increased 
slightly for both groups at the one-month follow-up.  A third ANOVA conducted on perceived 
efficacy of vaccination found a significant interaction effect, F(2,116) = 5.20, p = .007.  Follow-
up contrasts revealed a difference between groups immediately following the experiment, 
F(1,58) = 10.98, p = .002, but not at the follow-up, F(1,58) = 1.16, p = .286.  Bonferroni adjusted 
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t-tests verifies these findings by highlighting significant group differences at posttest, t(59.36) = -
2.308, p = .024.  Accordingly, Figure 14 illustrates the pronounced increase in perceived vaccine 
efficacy scores for the experimental group compared to the control following the intervention.  It 
also shows the decline in efficacy scores that occurred for both groups after one month.  Lastly, a 
repeated measures ANOVA conducted for perceived uncertainty related to Gardasil found no 
significant interaction effects, main effects for time or group, or trends (p>.05).  Bonferroni 
corrected post hoc t –tests revealed group differences at posttest that approached significance, t 
(59.45) = 2.064, p =.043.  As indicated in Figure 15, the IMB demonstrated more pronounced 
decreases in ratings of uncertainty from pretest to posttest, however ratings slightly increased at 
the one month follow-up; conversely, ratings of uncertainty steadily decreased across all three 
time periods for the attention control group.  
 
Perceived severity of cervical cancer.  A two way, repeated measures ANCOVAs was 
conducted to examine group differences in perceived seriousness of HPV and cervical cancer.  A 
significant interaction effect was found after controlling for sexual and vaccination status, F(2, 
116) = 4.353, p = .015.  Follow-up simple effects contrasts revealed a significant interaction 
effect only from pretest to posttest, F(1,59) = 10.13, p = .002.  Similarly, Bonferroni corrected 
post hoc t-tests revealed significant group differences at the posttest period only, t(60) = 2.917, p 
= .005.  As depicted in Figure 16, these results suggest that women in the experimental group 
experienced a significant decline in perceived severity scores immediately following the 
intervention, and perceptions of diagnostic severity only slightly increased over the one-month 
period.  In contrast, women in the control showed the opposite pattern; specifically, women in 
the control arm experienced a significant increase in perceived severity scores immediately 
following the study, and they experienced a subtle decrease in scores over the one-month period.   
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Discussion 
 
 The main purpose of this study was to examine the effectiveness of a theory-based, 
single-session, educational program to promote Gardasil use among undergraduate women 
enrolled at the University of Connecticut.  Study findings related to vaccine, cervical cancer, and 
HPV knowledge were consistent with what has been reported in the literature (Daley, Perrin, 
McDermott, Vamos, Rayko, & Packing-Ebuen, 2011; Gerend & Shepherd, 2011).  Specifically, 
this sample of undergraduate women demonstrated high levels of vaccine knowledge but in the 
context of lower mastery of HPV and cervical cancer information.  Following the experiment, as 
hypothesized the intervention condition was overall more effective in increasing vaccine, HPV, 
and cervical cancer knowledge when compared to an attention control group.  Specifically, this 
theory based educational approach was successful in improving women’s knowledge of Gardasil, 
HPV, and cervical cancer risk above and beyond that which can be attained through popular 
mediums readily available to the public.  In addition, it enhanced the likelihood that this 
information was maintained after one month.  Initial examination of the data shows that both the 
intervention and control group evidenced an increase in total knowledge scores across all 3 time-
points, suggesting that the experimental manipulation failed to engender substantial changes in 
knowledge scores.  Closer inspection of HPV and vaccine specific knowledge independently 
suggests that this effect is more likely an artifact of the components of the control arm.  
Specifically, participants in the control condition were given a standard Gardasil information 
sheet that imparted general information about the Gardasil vaccine.  Although few studies have 
explored the use of educational pamphlets to enhance HPV vaccine-specific knowledge in high 
risk populations, the use of informative flyers and pamphlets have led to notable increases in 
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vaccine knowledge (Gotvall, Tyden, Hoglund, & Larsson, 2010; Kennedy, Sapsis, Stokley, 
Curtis, & Gust, 2011).  In addition to getting vaccine-specific information, the educational 
videos used for the control group also communicated brief but general information about 
vaccination and HPV as these are topics commonly related to women’s health.  Nonetheless, 
despite these similarities, participants in the experimental group evidenced more pronounced 
increases in HPV and cervical cancer-specific knowledge that were maintained at the one-month 
follow-up.    Moreover, although both conditions demonstrated parallel increases in vaccine-
specific knowledge immediately following the manipulation, only the experimental group 
retained this knowledge base at the follow-up.  These findings are important and consistent with 
other studies that report similar improvements in cervical cancer risk, STD, and HPV-specific 
knowledge in response to a variety of educational approaches (Doherty & Graff Low, 2008; 
Gotvall et al, 2010; Jaworski & Carey, 2001; Warren, 2010).  Of particular import is the finding 
that the experimental manipulation led to sustained increases in vaccine specific knowledge 
despite similar exposure to vaccine-specific information across conditions, suggesting that 
participants in the experimental group derived additional benefits from the intervention.  It is 
possible that the provision of vaccine information alone without supplemental information 
highlighting the relationship between HPV, cervical cancer, and Gardasil makes it less likely that 
women will view the information as important and relevant.  In fact, HPV and cervical cancer 
risk perception was magnified immediately following the intervention for women in the 
experimental group alone.   Accordingly, individuals who do not find the information to be 
personal and relevant may be less likely to process and review the information over time 
(Shavitt, Vargas & Lowrey, 2004).  Secondly, the use of pamphlets or flyers alone may not be a 
sufficient medium for this information, as not everyone is invested in reading informational 
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sheets (Warren, 2010) or is capable of understanding the information (Waller, Marlow, & 
Wardle, 2007). In fact, studies in the marketing literature indicate that individuals who are 
interested in materials presented are more likely to be more attentive and to recall the 
information presented (Shavitt et al, 2004).  Nonetheless, in the context of low to moderate levels 
of HPV knowledge reported for this high risk population (Daley et al, 2011; Gerend & Shepherd, 
2011; Sandfort & Pleasant, 2009), these findings have important implications for cancer risk 
reduction, especially given the research linking knowledge of HPV and Gardasil to intentions to 
get vaccinated (Jones & Cook, 2008; Wong & Sam, 2007).   
 Unlike the notable improvements in knowledge scores, our theory that the intervention 
will enhance motivation to get vaccinated against HPV was partly supported.  Specifically, 
participants in the experimental condition demonstrated a significant change in four of the five 
indices of motivation targeted by the intervention: self-reported motivation, intentions, attitudes 
toward vaccination, and perceived risk for HPV and cervical cancer. These findings corroborate 
existing studies that have demonstrated similar shifts in some dimensions of motivation, 
specifically intentions and attitudes, following didactic strategies targeting Gardasil uptake (Cox 
et al, 2010; Doherty & Graff Low, 2008; Kennedy et al, 2011; Kepka, Coronado, Rodriguez, 
Thompson, 2012; Kwan, Tam, Lee, Chan, & Ngan, 2011; Patel et al, 2012).  For instance, 
Doherty and Graff Low (2008) determined that a web-based, self administered educational 
intervention was successful in generating significant improvements in knowledge and attitudes to 
HPV vaccination in a sample of mixed gendered college students.   Similarly, Patel et al (2012) 
reported high levels of intention and vaccine uptake six months post intervention in 
undergraduate women exposed to an HPV informational session compared to standard of care.  
Regarding our finding of improvements in self-rated motivation, there are no known studies to 
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date that attempt to alter perceptions of motivation to get vaccinated through health behavior 
interventions.  The paucity of studies that focus on generating motivational shifts is notable 
given the strong link between motivation and behavior change (Kalichman et al, 2008).  
Notwithstanding, the study’s focus on integrating evidence-based motivational strategies to 
enhance intrinsic motivation justifies the upward trend in members of the IMB group.  
Interestingly, improvement in these four indices ceased post-intervention, demonstrating a 
decrease in scores over the one-month follow-up.  Although unexpected, it may be that more 
than one intervention session is necessary to provoke enduring shifts in motivation.   
Nonetheless, in the context of low levels of motivation initially observed in this sample, these 
findings are important as the IMB model stresses the importance of motivation in inciting 
positive behavior change even amongst well-informed individuals (Fisher & Fisher, 2000). 
 Contrary to our hypothesis, the intervention was no more effective than an attention 
control group in engendering changes in social acceptability of Gardasil.  In fact, perceived 
social norms to getting vaccinated increased uniformly across both conditions immediately 
following the manipulation.  This outcome was surprising given the study’s emphasis on de-
stigmatizing HPV infection and vaccination behaviors by delivering risk and preventive 
information in a group setting; however, it remains in line with findings from other IMB driven 
interventions wherein perceived social norms for safe-sex behavior demonstrate resistance to 
change (Fisher et al, 1996; Jaworski & Carey, 2001). This pattern of results may be explained by 
the fact that health education was delivered in a group format for both conditions, thereby 
normalizing all women health topics regardless of subject matter or magnitude of coverage.  
Although the control group received limited information about HPV and Gardasil, it is plausible 
that discussing general themes associated with women’s health in a peer setting is sufficient to 
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modify perceived social norms for a myriad of health behaviors, including vaccine-seeking 
behaviors; however, this does not explain why the intervention did not elicit greater 
improvements in perceived vaccine acceptability given its focus on Gardasil.   More likely is the 
possibility that the questionnaire items used to assess for social norms tap into an aspect of social 
acceptability that is not attended to by the intervention (Fisher et al, 1996).  Specifically, 
questionnaire items inquire about the perceptions of people most important to participants though 
these individuals were not involved in the study itself.  Based on prior experiences with 
important family members, friends, and physicians, women in the intervention condition may not 
be convinced that others important to them will approve of the vaccine (Fisher et al, 1996).    
Indeed, studies show that parental approval and physician support are amongst the strongest 
indicators of vaccine behaviors (Bynum, Malo, Lee, Guillano, & Vadaparampil, 2011; Etter et al, 
2012; Grantham, Ahern, & Connolly-Ahern, 2011; Hollander, 2012; Hopfer, 2012; Malo, 
Hassani, Staras, Shenkman, Guiliano, & Vadaparampil, 2012; Rosenthal et al, 2011).  
Appropriately, many of the women in the study voiced an interest in pursuing Gardasil but were 
less likely to get vaccinated because their parents did not condone the vaccine and their 
physicians did not recommend it.  This evidence is disconcerting, as physicians have 
demonstrated reluctance towards discussing the vaccine with their patients as a result of time 
constraints, lack of initiation on behalf of the patient, negative perceptions of the vaccine, and 
perceived parental concerns (Etter et al, 2012; Malo et al, 2012; Quinn, Murphy, Malo, Christie, 
& Vadaparampil, 2012).  Accordingly, future research in this area may benefit from including 
important individuals, such as parents, in these group-based approaches in efforts to normalize 
HPV vaccination.  It is important to point out that, though nonsignificant, perceived social norms 
exhibited a steep decline for the control group while they remained relatively stable across time-
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points for the IMB group.  This is worthy of mention, as it suggests that the intervention may 
have exerted a change in social norms across time for the IMB group.  It is possible that 
discussion of Gardasil in a larger group context may have contributed to perceived peer 
acceptance, and this may be what is sustained across time-points; however, a larger sample size 
may be necessary to detect this subtle, but important, change (O’Grady et al, 2009).    
 The IMB model contends that even well intentioned and knowledgeable individuals 
require a set of skills to enable them to execute a health behavior (Fisher & Fisher, 2000).  
Behavioral skills are conceptualized as consisting of both objective and perceived (i.e., self-
efficacy) means of performing the behavior.  At pretest, both groups of women did not appear to 
have any thoughts regarding their beliefs in their ability to get vaccinated nor the level of effort 
involved, suggesting that these women may not have truly considered the steps one would take to 
get vaccinated.  Following the manipulation, both groups evidenced an initial increase and 
subsequent decease in perceived ability to overcome obstacles to getting vaccinated.  Also 
contrary to our prediction, the intervention did not elicit higher levels of perceived efficacy 
scores when compared to the control group.  Though surprising, this outcome is consistent with 
other studies that have employed brief interventions to guide skill acquisition (Jaworski & Carey, 
2001; O’Grady et al, 2009).  In fact, successful improvements in self-efficacy and perceived ease 
with engaging in target behaviors have been demonstrated in studies with lengthier intervention 
approaches that were delivered over a span of 3-5 days (Fisher et al, 1996; Fisher et al, 2002; 
Singh, 2003).  While there are other plausible factors that can explain this relationship, it is 
possible that these women did not have the opportunity to practice the skills they learned in 
session thereby leading to limited changes in perceived effectiveness and feasibility relative to 
the control group (Jaworski & Carey, 2001).  This improvement may also reflect the importance 
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of integrating expert opinion and peer support into messages promoting HPV vaccination, which 
was unaddressed in this study as noted by the lack of change in perceived norms.  Accordingly, 
one study founded on culture-centric narrative theory (Hopfer, 2012) determined that, relative to 
peer-led and expert-led narratives, a 4 minute narrative that combined both expert- and peer 
influence was most successful in enhancing vaccination self-efficacy (Hopfer, 2012).  This 
finding also makes sense given the IMB model’s premise that information and motivation are 
both essential in the process of skill acquisition, especially for more complex health behaviors 
(Fisher & Fisher, 2000).   
 As hypothesized, women who participated in the experimental arm reported significantly 
stronger intentions to get vaccinated in comparison to women in the control condition.  
Moreover, these women also exhibited overall greater intentions to engage in other behaviors 
associated with getting vaccinated, including procuring more vaccine-specific information and 
conversing with friends about the vaccine.  These findings are worthy of attention, as studies 
have identified a strong relationship between intentions and actual vaccination behaviors (Patel 
et al, 2012).  Nonetheless, a considerable number of barriers, including lack of physician and 
parental support, persist and likely contribute to the low vaccination rates widely reported in the 
literature (Patel et al, 2012).  Accordingly, these findings underscore the importance of 
identifying and addressing these barriers in future interventions.   
 Of equal import to the broader mission of cervical cancer prevention is the finding that 
the experimental group displayed greater intentions to comply with current screening standards.  
Recently, guidelines regarding cervical cancer screening underwent a fortuitous change, 
discouraging women from getting tested prior to age 21 and then only recommending screening 
every three years through age 30 (CDC, 2012).   Experts argue these changes are beneficial given 
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the fact that pap tests are limited in sensitivity and specificity and are therefore often 
unsuccessful in detecting a disease that takes years to progress (ACS, 2012; Patel et al, 2012).  
Furthermore frequent false positives incite anxiety in women undergoing testing and lead to 
unnecessary, prophylactic treatments (Patel et al, 2012).  Accordingly, our finding that women in 
the control condition are more likely to engage in frequent screening suggests they may be more 
susceptible to elevated distress in the context of limited benefits.   In addition, it is possible that 
women who are uninformed about HPV and cervical cancer may interpret changes in screening 
practices as an indication that screening is not important.  This raises concern, as there is existing 
research verifying underutilization of pap testing among young adult (Charlton, Corliss, 
Missmer, Frazier, Rosario, Kahn et al, 2011).  Given this evidence, the absence of screening 
behavior in the context of elevated risk suggests that vaccination is an even more valuable tool 
affording greater risk reduction.    
 Contrary to our hypothesis, women exposed to the IMB intervention did not engage in 
more preventive behaviors, including risky sexual practices, increasing regular pap smears, and 
taking steps to get vaccinated, in comparison to the attention control group.  In regards to our 
first outcome of interest, vaccine uptake, there were no group differences in Gardasil acquisition 
at the one-month follow-up.  While this outcome may be discouraging, it is reasonable given the 
short follow-up period.  In fact, the one study that explored the impact of an educational 
intervention on vaccine uptake in college students found no influence in vaccine uptake at 6 
months despite the inclusion of a reminder letter (Patel et al, 2012). It is possible that participants 
may be actively interested in getting vaccinated, however physical barriers such as distance from 
their gynecologist or PCP may render them unable to get vaccinated.  Although participants can 
seek vaccine information and procure the vaccine from other clinics, they may prefer speaking 
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about the vaccine with familiar physicians (Cermak, Cottrell, & Murnam, 2010; Hopfer, 2012; 
Krawcyk et al, 2012; Rosenthal et al, 2011).  It may also be that a longer follow-up time-point is 
needed to detect changes in vaccine uptake in this high-risk population.  Lack of access and 
infrequent visits to their physicians may also explain why there were no significant differences 
between conditions for behaviors related to completing pap screens. Furthermore, other work or 
school conflicts may be prioritized and therefore pose an obstacle to scheduling.  Nonetheless, an 
important discovery in Patel and colleagues (2012) study is their conclusion that vaccine 
intentions were related to vaccine uptake at the follow-up period, suggesting that an extended 
follow-up may help accentuate actual improvements in vaccine uptake.  This evidence is 
encouraging in light of our finding of significant improvements in cervical cancer behaviors for 
women in the experimental condition alone when within group differences across time were 
examined separately; in contrast, women in the control condition did not show any significant 
improvements in cancer preventive behaviors.         
 It is unclear why the experimental manipulation did not elicit more conversation about 
HPV or Gardasil with family or friends, however this null finding may be attributed to the fact 
that families were not incorporated into the active intervention.  As aforementioned, parental 
support is central to young women’s decision to get vaccinated (Bartlett & Peterson, 2011); it 
may be that participants are not comfortable broaching discussion of Gardasil and HPV with 
their parents by phone, especially if prior experience suggests parental disapproval.  Lastly, the 
lack of group differences in condom use at the one-month follow-up is consistent with studies 
that report limited improvements in sexual health behaviors following brief risk-reduction 
interventions (Gotvall et al, 2010; Jaworski & Carey, 2001). In fact, a similar study by Jaworski 
and Carey (2001) exploring the efficacy of a brief, one session intervention aimed at reducing 
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STD risk in an undergraduate female population found no improvements in condom use at the 
two month follow-up.   These authors suspect that women may hesitate broaching the subject of 
condom use while in committed relationships (Jaworski & Carey, 2001). Indeed, studies that 
have employed multi-session approaches have had more success in engendering changes in 
condom use behaviors and number of sexual partners (Fisher et al, 2002). These reports further 
substantiate our speculation that longer interventions and follow-up periods may be necessary to 
elicit and detect subtle changes in more complex health behaviors.    
 Lastly, our final hypothesis regarding the predictive capacity of the IMB model was not 
supported.  In its totality, all three of the components of the IMB model appear to be effective in 
predicting greater performance of preventive behaviors at the one-month follow-up, however not 
all of its elements were equally important.  Specifically, our findings indicate that only two 
factors, primarily perceived risk for HPV and cervical cancer as well as prior solicitation of 
Gardasil, drive this relationship.  Even more interesting is our finding that higher scores in these 
two factors yielded less likelihood of engaging in cervical cancer preventive behaviors.   The role 
of perceived risk in stimulating health behavior change has been widely explored in the literature 
through a variety of theoretical models and intervention approaches (Cracium, Schuz, Lippke, & 
Schwarzer, 2010; Schwarzer & Luszczynska, 2011; Weinstein, Lyon, Sandman, & Cuite, 1998) 
and reports remain inconsistent.  Some findings suggest that perceived risk of negative health 
consequences stimulates health behavior practice and reduction of risky sexual behaviors 
(Brewer, Weinstein, Cuite, Herrington, 2004; Lerman, Schwartz, Lin, Hughes, Narod, & Lynch, 
1997).  Conversely, other studies suggest that elevated levels of perceived risk can actually 
dissuade individuals from behavior change (Brewer et al, 2004; Wusu, 2011).  It is unclear why 
perceived risk played a large role in predicting cervical cancer screening behaviors in this study, 
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but this outcome is more likely an artifact of the small sample size.  Similarly, our finding that 
HPV vaccination history predicted fewer preventive behaviors is more likely due to the 
possibility that women who have already completed 1 of the 3 vaccine series may have been less 
inclined to engage in discussions with family or friends about the vaccine.   
 Despite the novelty of these findings, this study has several limitations.  Because this 
study recruited women from a convenience sample, the study findings are limited in 
generalizability and may not reflect the opinions of women beyond this particular sample.  
Importantly, these women were predominantly Caucasian, heterosexual, insured women enrolled 
in a local university.  Prior research has illustrated limited knowledge of HPV and 
underutilization of Gardasil among uninsured, low SES, minority and homosexual women (Cook 
et al, 2010; McCave,  2010; Niccolai et al, 2011; Liddon et al, 2012; Mcnair, Power, and Carr, 
2009), thus future studies should examine these attitudes among ethnic and sexually diverse 
groups as well as those who are lower in SES.  Similarly, future studies should be undertaken 
with men now that Gardasil recommendations have been extended to this group; vaccination of 
men can help further reduce transmission of HPV infection.  In addition to these psychosocial 
limitations, this study has some methodological shortcomings.  Firstly, the small sample size 
may have contributed to limited findings as some analyses were not sufficiently powered to 
detect small effects.  It is possible that a larger sample size may be necessary to detect even the 
most subtle behavioral changes, such as those related to vaccine receipt.  It is often difficult for 
women to schedule meetings with their physicians to discuss or pursue vaccination, as their 
college may be several states away from home and their doctors. Accordingly, despite good 
intentions, physical and academic obstacles may be realistic impediments to scheduling proximal 
doctor visits.  Accordingly, studies that follow women longitudinally are better equipped to 
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ascertain these behavioral effects (Patel et al, 2012).    A similar point, this intervention was 
delivered over a brief, one session visit.  An overwhelming majority of studies employing the 
IMB model deliver the intervention over a span of several sessions, and their findings often 
document successful intervention effects on health behaviors (O’Grady et al, 2009; Fisher et al, 
2002).  Nonetheless, while this can be considered a drawback, the development of brief 
programs to enhance cervical cancer preventive behaviors is warranted given the time 
limitations, the need for practical, generalizable programs, and the import of capturing the 
attention of this high risk population (Moore, Smith, & Folsom, 2012).    
 The group structure and format posed some additional limitations to this study.  Firstly, a 
systematic defect in the recruitment method led to large variability in group size and to the 
participation of women who identified as having completed the vaccine series.  Although 
statistically accounted for, differences in group size and composition can influence the diversity 
of viewpoints and topics presented during group discussion.  Nevertheless, in light of the broader 
picture, this problem is trivial given the fact that real-life application of this cancer prevention 
program will be carried out with a large, diverse body of undergraduate students, regardless of 
ethnicity, race, and/or vaccination status.  Moreover, given the evidence linking parental 
influence to vaccine uptake, future endeavors should consider ways to include both parents and 
undergraduate students within group interventions.  Also related to group structure and overall 
study design, future research designs should consider including a third control group that more 
closely resembles true standard of care, such as the Gardasil pamphlet that is readily available in 
clinic offices. Efforts to maintain group equivalence in this study may have led to the inclusion 
of elements that generated improvements in the IMB indices for members of the control group, 
thereby obfuscating group differences that would otherwise be larger (Patel et al, 2012).   
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 Lastly, there were some theoretically based limitations that could have influenced study 
results.  First, the scales used in this study were not all validated, as they were created and 
modeled after scales used in other studies based on Fisher and Fishers’ IMB model (Fisher et al, 
1996; Fisher et al, 2002).  As a result, alpha coefficients were low for some measures, although 
Cohen and Cohen (1983) argue that this would only reduce the effect of the intervention (as cited 
in Fisher, Fisher, Bryan, & Misovich, 2002).  In addition, to remain consistent with Fisher and 
Fisher’s (1992) model, future endeavors should utilize structural equation modeling (SEM) to 
confirm the model’s ability to predict vaccine uptake.   Furthermore, interventions based on the 
IMB model call for elicitation research prior to intervention development.  Although time 
limitations precluded us from adhering to these guidelines, it is important to note this 
intervention was still able to generate significant knowledge gains in women participating in the 
IMB program.  Lastly, the development of generalizable interventions requires an iterative 
process whereby effective components are modified and improved on based on study outcomes 
and participant feedback.  Qualitative data in the form of exit interviews would be a valuable 
supplement to future studies investigating the efficacy of this program, as they can help elucidate 
the feasibility and acceptability of the program prior to the coordination of larger scale studies.  
 In spite of these limitations, this study is one of the first to examine the influence of a 
theoretically based model in effecting changes in vaccine uptake as well as other health 
behaviors related to cervical cancer prevention among a high risk population.  The findings in 
this study are consistent with current research that suggest young women are generally aware of 
Gardasil, are less informed about HPV and cervical cancer, and are ambivalent about pursuing 
vaccination against HPV.  Furthermore, our findings indicate that the IMB model may accurately 
represent factors that play into young women’s decision to vaccinate against HPV, a highly 
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prevalent STD in this population.  Moreover, an IMB-based intervention may also provide 
universities with a powerful strategy to impel women to get vaccinated and also engage in 
ancillary, premptive behaviors, including sexual risk practices.   Recent changes in screening 
guidelines have shifted pap test initiation to occur during a time when students are graduating or 
in the midst of finding a job; as a result, they may experience changes or lapses in insurance 
coverage.  This is disconcerting, given some evidence that suggests HPV infections are less 
likely to clear with age (Harper et al, 2008). Under these circumstances, the development of 
programs that motivate women to get vaccinated is becoming even more vital to our movement 
towards cancer prevention.  This intervention is a step forward in providing universities with an 
inexpensive, brief and effective program that can be easily integrated and delivered to students 
and their families during school-wide orientation periods.  Therefore, future emphasis should be 
placed on validating the theoretical model and further examining its ability to incite vaccination 
behaviors in this at risk population.   
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Table 1  
 
Participant Demographic Information 
N = 62  % Responders (n) 
Age mean (range) 
 
 
 
18-21 
22-26 
 
19.21 (18-26) 
 
90.3 (n = 56) 
  9.7 (n = 6) 
Race/Ethnicity 
 
White/Caucasian 
Black/African American 
Asian 
Hispanic 
Other (unidentified multi-racial) 
 
66.1 (n = 41) 
  8.1 (n = 5) 
21.0 (n = 13) 
21.0 (n = 13) 
  4.8 (n = 3) 
  
Education 
 
 
Freshman 
Sophomore 
Junior 
Senior 
48.4 (n = 30) 
25.8 (n = 16) 
16.1 (n = 10) 
  9.7 (n = 6) 
        
 Work No 
Yes 
     Part Time 
     Summer 
48.4 (n = 30) 
51.6 (n = 32) 
35.5 (n = 22) 
16.1 (n = 10) 
        
 
Family Income 
 
 
< 40,000 
40,000 - 74,999 
75,000 - 150,000 
>150,000 
23.3 (n = 14) 
18.3 (n = 11) 
41.7 (n = 25) 
16.7 (n = 10) 
 
Religion 
 
None 
Catholic 
Protestant 
Islamic 
Jewish 
Other 
24.2 (n = 15) 
32.3 (n = 20) 
  9.7 (n = 6)  
  3.2 (n = 2) 
  3.2 (n = 2) 
27.4 (n = 17) 
 
Sexual Orientation  
 
 
Heterosexual 
Bisexual 
98.4 (n = 61) 
  1.6 (n = 1) 
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Table 2  
 
General Health Information 
 
 N = 62   
 
 
%  Responders (n) 
Health Insurance No 
Yes 
  8.1 (n = 5) 
91.9 (n = 57) 
Regular Physician No 
Yes 
12.9 (n = 8) 
87.1 (n = 54) 
Past Mental Health Diagnosis No 
Yes 
87.1 (n = 54) 
12.9 (n = 8) 
Past/Current Medical Diagnosis No 
Yes 
88.7 (n = 55) 
11.3 (n = 7)  
Past Familial History of Cancer No 
Yes 
40.3 (n = 25) 
59.7 (n = 37) 
Past Pap Screen 
 
 
 
No 
Yes 
72.6 (n = 45) 
27.4 (n = 17) 
*Age First Pap Younger than 16 
16 - 19 years old 
20 + 
  5.9 (n = 1) 
88.2 (n = 15) 
  5.9 (n = 1) 
   
*Last Pap Screen < 6 months ago 
~ 6 months to 1 year ago 
~ 1-2 years ago 
> 2 years ago 
  29.4 (n = 5) 
  35.0 (n = 6) 
  29.4 (n = 5) 
    5.8 (n = 1) 
History of Genital Warts No 
Yes 
 98.4 (n = 61) 
   1.6 (n = 1) 
Drugs No 
Yes 
90.3 (n = 56) 
  9.7 (n = 6) 
Exercise No 
Yes 
27.4 (n = 17) 
72.6 (n = 45) 
Alcohol Use No 
Yes 
48.4 (n = 30) 
51.6 (n = 32) 
Note.  *Percentages calculated based on number of pap screen completers only 
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Table 3 
Cervical Cancer Risk Behaviors 
 N = 62  % Responders (n) 
History of Sexually Transmitted 
Diseases (STDs) 
No 
Yes 
96.8 (n = 60) 
  3.2 (n = 2) 
Oral Contraceptive Use No 
Yes 
75.8 (n = 47) 
22.6 (n = 14) 
Sexual Experience Status 
 
Never Had Sex 
Yes Sex 
 
    *No current relationship 
    *Current relationship 
40.3 (n = 25) 
59.7 (n = 37) 
 
35.1 (n = 13) 
64.9 (n = 24) 
*Age at First Sexual Intercourse 12 - 14 years 
15 - 17 years 
18 +  
  5.4 (n = 2) 
56.8 (n = 21) 
37.8 (n = 14) 
*Number of Sexual Partners  
Past Year 
0 
1 
2 - 4 
5 - 7 
> 8  
  5.4 (n = 2) 
73.0 (n = 27) 
13.5 (n = 5) 
  5.4 (n = 2) 
  2.7 (n = 1) 
*Number of Sexual Partners 
Lifetime 
1 
2 - 4 
5 - 7 
> 8  
45.9 (n = 17) 
32.4 (n = 12) 
  8.1 (n = 3) 
13.5 (n = 5) 
*Frequency Condom Use Rarely 
Sometimes 
Usually 
Always 
10.8 (n = 4) 
  8.1 (n = 3) 
37.8 (n = 14) 
37.8 (n = 14) 
 
Past Cigarette Smoking No 
Yes 
79.0 (n = 49) 
21.0 (n = 13) 
Ever Delay Getting Pap Test No  
Yes 
58.1 (n = 36) 
32.3 (n = 20) 
Note.  *Percentages calculated based on total number of sexually active participants only 
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Table 4 
Sources of Information about the Human Papillomavirus (HPV) Vaccine 
  N = 62  % Responders 
(n) Ever Heard of HPV 
 
No 
Yes 
12.9 (n = 8) 
87.1 (n = 54) 
Ever Had HPV Test No 
Yes 
91.9 (n = 57) 
  8.1 (n = 5) 
Ever Heard of HPV Vaccine 
 
 
 
No 
Yes 
 
     PCP 
     Gynecologist 
     Other Doctor/Nurse 
     TV 
     Radio 
     Friend 
     Family 
     Magazine 
     Internet 
     Flyer 
21.0 (n = 13) 
79.0 (n = 49) 
 
27.4 (n = 17) 
22.5 (n = 14) 
33.9 (n = 21) 
50.0 (n = 31) 
  3.2 (n = 2) 
35.5 (n = 22) 
25.8 (n = 16) 
16.1 (n = 10) 
14.5 (n = 9) 
  6.5 (n = 4) 
Recommendation to Vaccinate PCP 
Gynecologist 
56.5 (n = 35) 
22.6 (n = 14) 
Preferred source of Vaccine 
Information 
Mom 
Friends 
Doctor 
School 
Internet 
Radio 
Newspaper 
Commercial 
 
  9.7 (n = 6) 
  4.8 (n = 3) 
83.9 (n  = 52) 
  3.2 (n = 2) 
21.0 (n = 13) 
  3.2 (n = 2) 
  6.5 (n = 4) 
  6.5 (n = 4) 
Perceived Gardasil Knowledge  Nothing at all 
A little 
A Moderate Amount 
17.7 (n = 11) 
59.7 (n = 37) 
22.6 (n = 14) 
Received at least one Gardasil dose No 
Yes 
83.9 (n = 52) 
16.1 (n = 10) 
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Table 5 
General Knowledge of Human Papillomavirus (HPV) and Cervical Cancer 
 % Correct (n) 
The virus associated with cervical cancer is transmitted by sex. 72.5 (n = 45) 
Cervical cancer and pre-cancer cells are associated with HPV. 71.0 (n = 44) 
Cervical cancer can be diagnosed by Pap tests. 74.2 (n = 46) 
CC prevention requires delayed sex, pap tests, and condom use. 74.2 (n = 46) 
HPV can cause genital warts.   40.3 (n = 25) 
HPV can live in skin without causing growths or changes. 48.4 (n = 30) 
Multiple sex partners increases risk for cervical cancer. 77.4 (n = 48) 
Having genital warts increases risk for cervical cancer. (false) 9.7  (n = 6) 
Having sex before age 18 increases risk for cervical cancer. 45.2 (n = 28) 
Taking illegal drugs increases risk for cervical cancer. (false) 41.9 (n = 26) 
Having contracted any sexually transmitted disease increases 
cervical cancer risk.   71.0 (n = 44) 
Smoking cigarettes increases risk for cervical cancer.      12.9 (n = 8) 
Poor diet or nutrition increases risk for cervical cancer.  (false)  45.2 (n = 28) 
Using tampons increases risk for cervical cancer. (false) 71.0 (n = 44) 
Using oral contraceptives increases risk for cervical cancer.       4.8  (n = 3) 
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Table 6 
General Knowledge of Human Papillomavirus (HPV) Vaccine 
 
 
% Correct (n) 
Girls/women who get the HPV vaccine need less frequent pelvic 
exams. (false)      91.9 (n = 57) 
Girls/women who get the HPV vaccine do not have to get Pap 
Smears. (false)    98.4 (n = 61) 
The HPV vaccine protects against all sexually transmitted infections.  
(false)    96.8 (n = 60) 
The HPV vaccine protects against cervical cancer. (true)    71.0 (n = 44) 
Girls/women who get the HPV vaccine can worry less about all 
sexually transmitted diseases. (false)    83.9 (n = 52) 
Girls who get the HPV Vaccine no longer need condoms during 
sex. (false) 100.0  (n = 62) 
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Table 7 
 
Predictors of Cervical Cancer Preventive Behaviors 
 
*p<.01.  **p < .001. 
 
 
 
 
 
 
 
 
 
                                          Model 1                                               Model 2 
Variable B SE B b B SE B b 
Age 
 
.06 
 
 
 
.15 .05 .06 .14 .05 
Past Gardasil Dose .10 .64 .02 -1.79 .60 -.37* 
Total Knowledge    .11 .09 .13 
Motivation    .18 .37 .11 
Intention    .06 .06 .26 
Social Norms    .06 .04 .22 
Perceived Risk    -.10 .04 -.31* 
R2  .00   .50  
F for change in R2  .08   6.43**  
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Figure 1.  The Information Motivation Behavioral Skills Model  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  This figure represents the IMB model as it is applied to Gardasil Vaccination. Adapted 
from "The Information-Motivation-Behavioral Skills Model:  A General Social Psychological 
Approach to Understanding and Promoting HealthBehavior.”  by Fisher, Fisher, and Harman 
(2003). Application of the Protection Motivation Theory to Genetic Testing for Breast Cancer 
Risk.  Social Psychological Foundations of Health & lllness (pp. 82-106).  Malden, MA; 
Blackwell Publishing Ltd.  
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Figure 2.  Estimated Marginal Means for Total Knowledge Scores for Condition Across Time 
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Figure 3.  Estimated Marginal Means for Vaccine Knowledge for Condition Across Time 
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Figure 4.  Estimated Marginal Means for HPV and Cervical Cancer Knowledge for Condition 
Across Time 
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Figure 5.  Estimated Marginal Means for Motivation to get Vaccinated for Condition Across 
Time 
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Figure 6.  Estimated Marginal Means for Vaccination Intentions for Condition Across Time 
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Figure 7.  Estimated Marginal Means for Vaccination Attitudes for Condition Across Time 
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Figure 8.  Estimated Marginal Means for Perceived Social Norms for Vaccination for Condition 
Across Time 
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Figure 9.  Estimated Marginal Means for Perceived Risk of HPV and Cervical Cancer for 
Condition Across Time 
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Figure 10.  Estimated Marginal Means for Self-Efficacy to Get Vaccinated for Condition Across 
Time 
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Figure 11.  Estimated Marginal Means for Perceived Difficulty to get Vaccinated for Condition 
Across Time 
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Figure 12.  Estimated Marginal Means for Perceived Harm of Gardasil Vaccination for 
Condition Across Time 
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Figure 13.  Estimated Marginal Means for Perceived Barriers of Gardasil Vaccination for 
Condition Across Time 
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Figure 14.  Estimated Marginal Means for Perceived Efficacy of Gardasil Vaccine for Condition 
Across Time 
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Figure 15.  Estimated Marginal Means for Perceived Uncertainty Toward Gardasil for Condition 
Across Time 
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Figure 16.  Estimated Marginal Means for Perceived Severity of Vaccination for Condition 
Across Time 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
